Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division
In Brief: Carnegie Mellon President Emeritus honored By UPCI; Schiffer Leaves Maryland for Detroit
Reinventing NCI: Rimer Says Report Consistent with Her Goals For DCCPS
Patient Advocacy: congress Delivers Symbolism, Not Solution, Visco Says
Cancer Policy; Cost Containment Impedes Research, Cancer Panel Finds
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation